1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1610
  5. Art Unit 1619
  6. Examiner Mitchell

Examiner Mitchell Edwin C

1619-MITCHELL-EDWIN-C

Employment Information

Art Unit:1619 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
504 — Plant protecting and regulating compositions
435 — Chemistry: molecular biology and microbiology
Phone:(571) 272-7007
Email:edwin.mitchell@uspto.gov
Location:VA 22314
Title:Pat Examnr Gen Chem
Service:4 years
Grade:GS-12

Grant Rate and Difficulty Ranking

93
3-Year Grant rate: 21% over 34 cases
Difficulty: Extremely Hard
Difficulty Percentile: 93rd

With Examiner Mitchell, you have a 21% chance of getting an issued patent by 3 years after the first office action. Examiner Mitchell is an extremely hard examiner and in the 93rd percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Mitchell, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1619

Examiner Mitchell's grant rate is lower than that of Art Unit 1619 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Mitchell 2.5
Art Unit 1619 2.4

Interview Benefit

Grant Rate without Interview

Examiner Mitchell has granted 5 of 24 cases without any applicant-requested interviews for a grant rate of 21%.

Grant Rate with Interview

Examiner Mitchell has granted 2 of 10 cases with at least one applicant-requested interview for a grant rate of 20%.

Interview Benefit

With Examiner Mitchell, conducting an interview decreases your chance of getting a patent granted by 5%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17765262 Nano-Particulate Compositions For Stimulating Host Innate Immune Responses For Therapeutic Applications Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
17540475 Transdermal Pharmaceutical Formulations For The Treatment Of Cancer Abandoned View
17756672 Compositions Comprising Hyper Harmonized Hydroxyl Modified Fullerene Substances Patented View
17427190 Polymeric Implants With High Drug Loading And Long-Acting Drug Release And Methods Of Making The Same Patented View
17296571 Aqueous Paediatric Retinol Formulations Patented View
16966667 Pyridazinol Compounds And Derivatives, Preparation Methods, Herbicidal Compositions And Applications Thereof Patented View
18625181 Methods Of Treating Or Reducing Symptoms Of Opiate Dependency (Addiction) Via Combination Therapy With Vaccine/antibodies And 5ht1/5ht2, Sert And Opiate Allosteric Modulators Abandoned View
17744529 Composition For Enhancing Skin Elasticity Or Improving Skin Wrinkles Abandoned View
17280979 Wood Preservatives Patented View
18136391 Cervidae Deer Family Antler Pet Chew With Health Additives And Method Of Use And Making Abandoned View
17465978 Reconstitutable Sanitiser Abandoned View
18685970 Crystalline Forms Of Methyl 2-[2-[2-Bromo-4-Fluoro-5-[3-Methyl-2,6-Dioxo-4-(Trifluoromethyl)pyrimidin-1-Yl]phenoxy]phenoxy]-2-Methoxy-Acetate Abandoned View
18456758 Methods For Maintaining Concentrations Of Volatile Lipophilic Compounds In Manufacture Of Compositions And Dosage Forms Abandoned View
18100563 Aqueous Formulation Including Dissolved Hydrogen Gas And Minerals And Additives Patented View
17680116 Skin Serum And Process Of Making The Same Abandoned View
18625137 Methods Of Treating Or Reducing Symptoms Of Stimulant Dependency (Addiction) Via Combination Therapy With Vaccine/antibodies And 5ht1/5ht2, Sert And Glutamate Allosteric Modulators Abandoned View
17354373 Stable Acyclovir Sodium Parenteral Formulation Abandoned View
18625131 Methods Of Treating Or Reducing Symptoms Of Anxiety, Depression, Attention Deficiency (Add), Attention Deficient Hyperactivity (Adhd), Obsessive Compulsive (Ocd), Bipolar Disorder, And Related Disorders/conditions Via Combination Therapy With Vaccine/antibodies And 5ht1/5ht2, Sert And Other Allosteric Modulators. Abandoned View
17311933 Salt-Sensitive Particles Abandoned View
17359193 Stable Cannabinoid Compositions Abandoned View
17667147 Methods Of Use And Formulations Of Allosteric Modulators Of The Serotonin, Dopamine And Other Receptor Systems For Medical, Recreational, Religious, Research And Other Uses. Abandoned View
17442282 Particles For Cell Adhesion And Utilization Thereof Abandoned View
17803152 Tunable Leukocyte-Based Biomimetic Nanoparticles And Methods Of Use Abandoned View
17608347 Di-Thioester Cationic Lipids Patented View
18616121 Methods Of Treating Or Reducing Symptoms Of Nicotine Dependency (Addiction) Such As Tobacco-Use (Smoking, Vaping, Sublingual, Oral) And/or Tobacco Smoking Cessation Via Combination Therapy With Allosteric Modulators And Phenethylamines. Abandoned View
16500388 Kit For Treating Or Relieving Pain At Incision Site Following Surgical Procedure Abandoned View
17544228 Stable Dispersions Of Silver Nanoparticles And Methods Of Preparation Thereof Patented View
17274223 Fungicidal Nitroanilino Substituted Pyrazoles Patented View
17603566 Empty Porous Particles For Use In Treatment, Prevention And/or Postponement Of Degeneration Of Neurodegenerative Diseases, Neurons And Glia Abandoned View
17773981 Production And Use Of Compacted Collagen Abandoned View
17564268 Lyophilized Powder Of Latamoxef Sodium For Injection And Lyophilization Method Thereof Patented View
18616089 Methods Of Treating Or Reducing Symptoms Of Brain Cancer Such As Glioma And Glioblastoma Via Combination Therapy With Allosteric Modulators And Phenethylamines. Abandoned View
17268769 Method For Preparing Microcapsule Patented View
17290522 Mamc-Mediated Biomimetic Nanoparticles Abandoned View
16916594 Cosmetic Compositions Capable Of Forming A Multilayer Structure After Application To A Keratinous Material Containing A Combination Of Silicone Resins Patented View
17183157 Immobilization Of Plant Growth Promoting Microorganisms In Hydrophobic Carriers Abandoned View
17560328 Creamy Hydrating Cosmetic Composition In A Water Release Emulsion Patented View
17219295 Methods And Compositions For Drug Delivery Abandoned View
17235314 Transdermal And/or Topical, Pharmaceutical Formulations Comprising Cannabidiol And/or Tetrahydrocannabinol For The Treatment Of Chronic Pain Abandoned View
17046726 Method Of Controlling Soil-Borne Diseases Of Plants Abandoned View
17610660 Polymer-Lipid Nanocomplex For Enhanced Aqueous Solubilisation And Absorption Of Hydrophobic Active Compounds Abandoned View
17238809 Self-Assembling Oxygen Carrier Compositions Patented View
17383817 Functionalized Set Of Carbon Atoms In The Sp2 Hybridization State, A Method For Preparing It And Its Uses, In Particular For Rendering A Surface Antibacterial Abandoned View
16986745 Plant Health With In Situ Formed Water Absorbing Hydrogels Abandoned View
17612159 Methods And Compositions For Treating Undesired Implanted Tissue Filler Patented View
17467955 Skin Care Formula, Skin Care Products, And Methods Of Making The Same Patented View
17413091 Composition Comprising A Polysaccharide, A Polyol And A Specific Ester Abandoned View
17047222 Haircare Composition Comprising Modified Vegetable Waxes Patented View
17721840 Medicated Drink Abandoned View
17250714 Container System And Pharmaceutical Foam Composition Comprising Betamethasone Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.